Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Filing Raw Material Inspection Reports – V 2.0

Posted on By

SOP for Filing Raw Material Inspection Reports – V 2.0

Procedure for Filing Raw Material Inspection Reports

Department Quality Control (QC)/Quality Assurance (QA)/Warehouse
SOP No. SOP/Ointment/154
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic method for filing raw material inspection reports in pharmaceutical manufacturing. Proper documentation of raw material inspections ensures compliance with Good Manufacturing Practices (GMP), regulatory requirements, and traceability.

2. Scope

This SOP applies to personnel in the Quality Control (QC), Quality Assurance (QA), and Warehouse departments responsible for receiving, inspecting, and filing raw material inspection reports for all incoming materials used in production.

3. Responsibilities

  • Warehouse Personnel: Initiates the raw material receiving process and records preliminary observations.
  • Quality Control (QC) Analyst: Conducts physical, chemical, and microbiological testing of raw materials and records results.
  • QA Officer: Reviews raw material inspection reports for completeness and compliance.
  • QA Manager: Approves and ensures proper filing and archiving of inspection records.

4. Accountability

The QA and QC Managers are accountable for ensuring that all raw material inspection reports are filed and maintained in compliance with GMP, FDA, ICH, and WHO regulations.

See also  Ointments: SOP for Ensuring Calibration of Critical Instruments - V 2.0

5. Procedure

5.1 Types of Raw Material Inspection Reports

The following types of reports must be maintained:

  • Raw Material Receiving
Report: Contains information on material name, supplier details, batch number, and preliminary inspection findings.
  • Raw Material Test Report: Includes results of physical, chemical, and microbiological tests conducted on the raw material.
  • Certificate of Analysis (CoA): Provided by the supplier, detailing the material’s specifications and test results.
  • Raw Material Acceptance/Rejection Report: Documents final decision on whether the material is approved for use or rejected.
  • 5.2 Raw Material Receiving and Preliminary Inspection

    • Upon arrival, warehouse personnel must check the material against the purchase order.
    • The following parameters must be recorded:
      • Material name and description.
      • Supplier name and details.
      • Batch number and manufacturing/expiry date.
      • Quantity received and condition of packaging.
    • All details must be documented in the **Raw Material Receiving Report**.
    • Warehouse personnel must label the material as **”Quarantine”** until QC testing is completed.

    5.3 Raw Material Testing by Quality Control (QC)

    • QC personnel must collect representative samples from each batch following the **sampling plan**.
    • Tests must be conducted according to predefined specifications, including:
      • Physical properties (appearance, odor, color, density).
      • Chemical composition (pH, solubility, purity, assay).
      • Microbiological testing (bioburden, endotoxin levels, sterility).
    • Test results must be recorded in the **Raw Material Test Report**.
    • The QC analyst must compare results with the supplier’s Certificate of Analysis (CoA).
    • If test results meet acceptance criteria, the material is **approved** and moved to the **Approved Storage Area**.
    • If test results do not meet specifications, the material is **rejected** and moved to the **Rejection Area**.

    5.4 Review and Approval of Inspection Reports

    • QA personnel must review all reports for accuracy and completeness.
    • The **Raw Material Acceptance/Rejection Report** must be completed and signed by the QA Manager.
    • All reports must be cross-verified with the CoA and supplier documents.
    • Any discrepancies or deviations must be investigated and documented.

    5.5 Filing and Archiving of Raw Material Inspection Reports

    • All raw material inspection reports must be stored in a designated filing system.
    • Reports must be categorized by **material name, batch number, and supplier name**.
    • Electronic copies of reports should be scanned and backed up in the document management system.
    • Retention period:
      • Approved materials – **Minimum 5 years**.
      • Rejected materials – **Minimum 3 years**.
    • QA must ensure records are readily available for audits and regulatory inspections.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • CoA – Certificate of Analysis
    • FDA – Food and Drug Administration
    • ICH – International Council for Harmonisation

    7. Documents

    • Raw Material Receiving Report Template (Annexure-1)
    • Raw Material Test Report Template (Annexure-2)

    8. References

    • ICH Q7 – Good Manufacturing Practice Guide
    • WHO Guidelines on Raw Material Testing
    • US FDA Guidance on Raw Material Inspection

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Raw Material Receiving Report Template

    Date Material Name Batch No. Supplier Quantity QA Approval
    01/02/2025 API-01 12345 Supplier X 500 kg Approved

    Annexure-2: Raw Material Test Report Template

    Date Material Name Batch No. Test Conducted Results QC Analyst QA Approval
    02/02/2025 API-01 12345 Purity Test 99.8% John Doe Approved

    12. Revision History

    Revision Date Revision No. Details Reason Approved By
    02/02/2025 2.0 Expanded Procedure Improved Documentation QA Head
    See also  Ointments: SOP for Preventing Contamination at Each Stage - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Creams: SOP for Microbial Challenge Testing of Cream Formulations – V 2.0
    Next Post: Capsule: SOP for Production Reconciliation Reports for Capsules – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version